GranuFlo Litigation Update


Certain dialysis products such as GranuFlo and NaturaLyte carry increased risks of serious injury or even death. This increased risk is linked to elevated levels of bicarbonate in the body, a contributing factor in cardiac arrest. Even the FDA has issued a recall of GranuFlo. The FDA warned consumers that the increased sodium bicarbonate levels may contribute to metabolic alkalosis, which is a significant risk factor associated with low blood pressure, hypokalemia, hypoxemia, hypercapnia and cardiac arrhythmia, which, if not... Read More

GranuFlo and NaturaLyte Cause Trouble for Da Vita Healthcare

Related to lawsuits filed against Fresenius Medical Care in connection with its dialysis products GranuFlo and NaturaLyte, lawsuits are now being filed against the dialysis treatment center, Da Vita Healthcare, in connection with their administration of GranuFlo and NaturaLyte. GranuFlo and NaturaLyte are drugs used in hemodialysis to treat patients suffering from kidney disease and/or failure.  The products were recalled by the FDA in March 2012 mandating revisisons to prescribing instructions to include the health risks connected with the use of... Read More